Dudley Timothy Robinson
#459 Bacteriuria in patients undergoing intradetrusor onabotulinumtoxinA injections for refractory neurogenic detrusor overactivity: Do we need antibiotic prophylaxis?
Leitner L1, Sammer U2, Walter M2, Knüpfer S C2, Schneider M P2, Seifert B3, Mehnert U2, Kessler T M21. Neuro-Urology, Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital and Department of Urology, University Hospital Basel, 2. Neuro-Urology, Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital, 3. Epidemiology, Biostatistics and Prevention Institute, Department of Biostatistics, University of Zürich
Clinical Trial, Prospective Study, Infection, Urinary Tract
#460 Different types and dosages of intradetrusor Botulinum Toxin A injections in spinal cord patients: a single centre experience in 15-years follow-up.
Musco S1, Del Popolo G1, Celso M1, Bellio E1, Bellio V1, Lombardi G11. Neuro-Urology Dept, University Hospital Careggi, Florence, Italy
Incontinence, Detrusor Overactivity, Retrospective Study, Spinal Cord Injury
#461 Comparison of intradetrusor injections of botulinum toxin A in adult patients with spina bifida and in patients with spinal cord injury : a multicenter study
Peyronnet B1, Hascoet J1, Castel-Lacanal E2, Roumiguie M2, Senal N1, Kerdraon J1, Marque P2, Manunta A1, Gamé X21. Rennes University Hospital, 2. Toulouse University Hospital
Spinal Cord Injury, Conservative Treatment, Detrusor Overactivity, Neuropathies: Central
#462 Intradetrusor injections of botulinum toxin A in patients with spinal dysraphism: results of a multicenter study
Peyronnet B1, Even Schneider A2, Verrando A3, De Sèze M4, Hascoet J1, Castel-Lacanal E5, Chartier-Kastler E6, Schurch B7, Denys P2, Manunta A1, Amarenco G3, Gamé X51. Rennes University Hospital, 2. Raymond Poincaré Hospital, 3. Tenon Hospital, 4. Saint-Augustin institute, 5. Toulouse University Hospital, 6. Pitié-Salpétrière Hospital, 7. Lausanne University Hospital
Neuropathies: Central, Detrusor Overactivity, Conservative Treatment
#463 Deficits of urothelial E-cadherin and zonula occludens-1 in chronic spinal cord injured bladders improved after repeated detrusor onabotulinumtoxinA injections
Chen S1, Lee Y1, Lee C1, Chang J1, Kuo H11. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
Physiology, Basic Science, Neuropathies: Peripheral
#464 Long term real life efficacy of onabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in a population using intermittent self-catheterization.
Joussain C1, Popoff M2, Phé V3, Even Schneider A2, Falcou L2, Chartier-Kastler E4, Schurch B5, Denys P61. Medical School Paris Île-de-France Ouest, Inserm U1179, Versailles Saint-Quentin University, Versailles, France. - Paris Saclay, 2. Department of Physical Medicine and Rehabilitation, Hôpital Raymond-Poincaré AP-HP, Garches, France, 3. Pitié-Salpêtrière Academic Hospital, Department of Urology, Assistance Publique-Hôpitaux de Paris, Pierre and Marie Curie Medical School, Paris 6 University, Paris, France, 4. Pitié-Salpêtrière Academic Hospital, Department of Urology, Assistance Publique-Hôpitaux de Paris, Pierre and Marie Curie Medical School, Paris 6 University, Paris, France., 5. Neuropsychology and Neurorehabilitation Service, Department of Clinical Neuroscience, Lausanne University Hospital, Lausanne, Switzerland, 6. Medical School Paris Île-de-France Ouest, Inserm U1179, Versailles Saint-Quentin University, Versailles, France. Department of Physical Medicine and Rehabilitation, Hôpital Raymond-Poincaré AP-HP, Garches, France
Overactive Bladder, Detrusor Overactivity, Incontinence, Spinal Cord Injury, Multiple Sclerosis
#465 Long-term follow-up of patients who failed intravesical botulinum toxin A injections
Marcelissen T1, Rahnama'i S2, Brierly B3, de Vries P21. Maastricht University Medical Centre, 2. Zuyderland Medical Centre, Heerlen, 3. Maastricht University
Female, Incontinence, Overactive Bladder
#466 Botulinum toxin urethral sphincter injection as treatment for non-neurogenic voiding dysfunction – A randomized, double-Blind, placebo-controlled study
Jiang Y1, Wu S1, Lee C1, Kuo H11. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
Clinical Trial, Pathophysiology, Voiding Dysfunction
#467 Redefining the indication to repeat onabotulinum toxin A in patients with neurogenic detrusor overactivity (NDO) after spinal cord injury (SCI).
Suman D11. Isic ,New Delhi
Incontinence, Spinal Cord Injury, Detrusor Overactivity, Retrospective Study
#468 Assessment of pain during administration of botulinum toxin bladder injections with and without the use of intravesical lidocaine instillation
Shin S1, Hadjipavlou M2, Sharma D2, Sabbagh S21. St George's University of London, 2. St George's University Hospitals NHS Foundation Trust
Detrusor Overactivity, Overactive Bladder, Pain, other, Questionnaire, Retrospective Study
#469 Efficacy and safety of botulinum toxin A treatment for patients with detrusor overactivity and inadequate contractility
Wang C1, Jiang Y2, Ong H2, Tian J2, Kuo H21. Department of Urology, En Chu Kong Hospital, New Taipei City, Taiwan, 2. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
Pharmacology, Incontinence, Underactive Bladder
#470 DOES INTRAPROSTATIC INJECTION OF BOTULINUM TOXIN-A REDUCE POST-VOID RESIDUAL IN BENIGN PROSTATIC HYPERPLASIA?
Andretta E1, Viaggi S2, Pastorello M3, Seren P4, Artuso G51. Urology Department - General Hospital DOLO (Venice) ITALY, 2. MediNeos Observational Research – MODENA, 3. Urology Department - General Hospital NEGRAR (Verona), 4. Urology Department - General Hospital DOLO (Venice), 5. Urology Department - General Hosptal DOLO (Venice)
Benign Prostatic Hyperplasia (BPH), Prospective Study, Conservative Treatment